ZA84959B - Certain benzazocinone and benzazoninone derivatives - Google Patents

Certain benzazocinone and benzazoninone derivatives

Info

Publication number
ZA84959B
ZA84959B ZA84959A ZA84959A ZA84959B ZA 84959 B ZA84959 B ZA 84959B ZA 84959 A ZA84959 A ZA 84959A ZA 84959 A ZA84959 A ZA 84959A ZA 84959 B ZA84959 B ZA 84959B
Authority
ZA
South Africa
Prior art keywords
derivatives
benzazoninone
benzazocinone
certain
benzazonin
Prior art date
Application number
ZA84959A
Other languages
English (en)
Inventor
Jeffrey William Herber Watthey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA84959B publication Critical patent/ZA84959B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA84959A 1983-02-10 1984-02-09 Certain benzazocinone and benzazoninone derivatives ZA84959B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/465,696 US4470988A (en) 1983-02-10 1983-02-10 Benzazocinone and benzazoninone derivatives, and their pharmaceutical use

Publications (1)

Publication Number Publication Date
ZA84959B true ZA84959B (en) 1984-09-26

Family

ID=23848809

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA84959A ZA84959B (en) 1983-02-10 1984-02-09 Certain benzazocinone and benzazoninone derivatives

Country Status (20)

Country Link
US (1) US4470988A (xx)
EP (1) EP0119161B1 (xx)
JP (1) JPS59172474A (xx)
KR (1) KR840007872A (xx)
AT (1) ATE44279T1 (xx)
AU (1) AU2443184A (xx)
CA (1) CA1218989A (xx)
DD (1) DD216717A5 (xx)
DE (1) DE3478810D1 (xx)
DK (1) DK58084A (xx)
ES (2) ES8606286A1 (xx)
FI (1) FI840463A (xx)
GR (1) GR81766B (xx)
HU (1) HU193671B (xx)
IE (1) IE56816B1 (xx)
IL (1) IL70882A0 (xx)
NO (1) NO840486L (xx)
NZ (1) NZ207090A (xx)
PT (1) PT78064B (xx)
ZA (1) ZA84959B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873235A (en) * 1982-06-01 1989-10-10 Merck & Co., Inc. Benzofused lactams as antihypertensives
US4537885A (en) * 1983-02-10 1985-08-27 Ciba Geigy Corporation Certain benzazocinone and benzazoninone derivatives
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5145864A (en) * 1987-09-15 1992-09-08 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5646276A (en) * 1992-05-13 1997-07-08 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
RU2124503C1 (ru) 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
ES2162907T3 (es) * 1993-11-22 2002-01-16 Merck & Co Inc 3-acilaminobenzacepinas.
US5658901A (en) * 1994-08-18 1997-08-19 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
WO1996040656A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
WO2011110277A1 (en) 2010-03-11 2011-09-15 Merck Patent Gmbh Fibers in therapy and cosmetics
CN118748991A (zh) * 2022-03-23 2024-10-08 浙江华海药业股份有限公司 一种纯化左乙拉西坦中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1191963A (en) * 1968-02-07 1970-05-13 Ucb Sa Heterocyclic Compounds
GB1183442A (xx) * 1968-02-23 1970-03-04
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel
IL63540A0 (en) * 1980-08-18 1981-11-30 Merck & Co Inc Substituted enantholactam derivatives as antihypertensives
GR74635B (xx) * 1980-08-18 1984-06-29 Merck & Co Inc
GR74625B (xx) * 1980-08-18 1984-06-29 Merck & Co Inc
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents

Also Published As

Publication number Publication date
CA1218989A (en) 1987-03-10
EP0119161B1 (de) 1989-06-28
PT78064B (en) 1986-06-02
JPH0449545B2 (xx) 1992-08-11
ATE44279T1 (de) 1989-07-15
DK58084D0 (da) 1984-02-09
IE840301L (en) 1984-08-10
EP0119161A2 (de) 1984-09-19
AU2443184A (en) 1984-08-16
FI840463A0 (fi) 1984-02-06
HU193671B (en) 1987-11-30
EP0119161A3 (en) 1986-06-11
DD216717A5 (de) 1984-12-19
DK58084A (da) 1984-08-11
NO840486L (no) 1984-08-13
US4470988A (en) 1984-09-11
DE3478810D1 (en) 1989-08-03
FI840463A (fi) 1984-08-11
IL70882A0 (en) 1984-05-31
ES8606286A1 (es) 1986-04-01
ES544051A0 (es) 1986-09-16
IE56816B1 (en) 1991-12-18
ES8700240A1 (es) 1986-09-16
JPS59172474A (ja) 1984-09-29
GR81766B (xx) 1984-12-12
NZ207090A (en) 1985-10-11
KR840007872A (ko) 1984-12-11
ES529593A0 (es) 1986-04-01
PT78064A (en) 1984-03-01

Similar Documents

Publication Publication Date Title
IL70882A0 (en) Certain benzazocinone and benzazoninone derivatives
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
IL128205A0 (en) Potassium channel inhibitors and pharmaceutical compositions containing the same
HK1020058A1 (en) Bicyclic pyrimidine derivatives and their use as anti-coagulants
AP9901478A0 (en) Compounds for the treatment of ischemia.
ES8307263A1 (es) Un procedimiento para la preparacion de fosfonamidas sustituidas.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
SE8503680D0 (sv) Indolderivat
IL129056A0 (en) Monocyclic N-heterocyclics substituted by thio acid derivatives and pharmaceutical compositions containing same
BG103417A (en) Condensed pyrimidine bicyclic derivatives
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
IL125285A0 (en) Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and pharmaceutical compositions containing the same
AP9801269A0 (en) Prostaglandin agonists.
EP0758312A4 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
ES8602631A1 (es) Procedimiento de producir compuestos para tratar la hipertension
ES8205126A1 (es) Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina.
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora